{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:39:13Z","timestamp":1769128753381,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,1,31]]},"DOI":"10.1038\/s41416-025-03198-9","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:11:14Z","timestamp":1762524674000},"page":"331-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Profilin-2 promotes tumour aggressiveness in oral squamous cell carcinoma via HDAC1 modulation: implications for EMT and targeted therapy"],"prefix":"10.1038","volume":"134","author":[{"given":"Li-Han","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0385-869X","authenticated-orcid":false,"given":"Chung-Ji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"3198_CR1","doi-asserted-by":"publisher","first-page":"784924","DOI":"10.3389\/fonc.2021.784924","volume":"11","author":"EDS Dolens","year":"2021","unstructured":"Dolens EDS, Dourado MR, Almangush A, Salo TA, Gurgel Rocha CA, da Silva SD, et al. The impact of histopathological features on the prognosis of oral squamous cell carcinoma: a comprehensive review and meta-analysis. Front Oncol. 2021;11:784924. https:\/\/doi.org\/10.3389\/fonc.2021.784924.","journal-title":"Front Oncol"},{"key":"3198_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"3198_CR3","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1200\/JCO.2015.61.2929","volume":"33","author":"SB Chinn","year":"2015","unstructured":"Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol. 2015;33:3269\u201376. https:\/\/doi.org\/10.1200\/JCO.2015.61.2929.","journal-title":"J Clin Oncol"},{"key":"3198_CR4","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1080\/14656566.2021.1948011","volume":"22","author":"S Kumar","year":"2021","unstructured":"Kumar S, Noronha V, Patil V, Joshi A, Menon N, Prabhash K. Advances in pharmacotherapy for head and neck cancer. Expert Opin Pharmacother. 2021;22:2007\u201318. https:\/\/doi.org\/10.1080\/14656566.2021.1948011.","journal-title":"Expert Opin Pharmacother"},{"key":"3198_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105701","volume":"125","author":"AI Mendez","year":"2022","unstructured":"Mendez AI, Wihlidal JGJ, Eurich DT, Nichols AC, MacNeil SD, Seikaly HR. Validity of functional patient-reported outcomes in head and neck oncology: a systematic review. Oral Oncol. 2022;125:105701. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105701.","journal-title":"Oral Oncol"},{"key":"3198_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0983-5","volume":"18","author":"B Peltanova","year":"2019","unstructured":"Peltanova B, Raudenska M, Masarik M. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer. 2019;18:63. https:\/\/doi.org\/10.1186\/s12943-019-0983-5.","journal-title":"Mol Cancer"},{"key":"3198_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrc.2018.11","volume":"18","author":"CR Leemans","year":"2018","unstructured":"Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18:269\u201382. https:\/\/doi.org\/10.1038\/nrc.2018.11.","journal-title":"Nat Rev Cancer"},{"key":"3198_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1769-9","volume":"10","author":"E Alsahafi","year":"2019","unstructured":"Alsahafi E, Begg K, Amelio I, Raulf N, Lucarelli P, Sauter T, et al. Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell Death Dis. 2019;10:540. https:\/\/doi.org\/10.1038\/s41419-019-1769-9.","journal-title":"Cell Death Dis"},{"key":"3198_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10142-023-01002-6","volume":"23","author":"Y Ji","year":"2023","unstructured":"Ji Y, Zhao Z, Cheng Y, Bu W, Zhao X, Luo Y, et al. Special transcriptome landscape and molecular prognostic signature of non-smoking head and neck cancer patients. Funct Integr Genomics. 2023;23:79. https:\/\/doi.org\/10.1007\/s10142-023-01002-6.","journal-title":"Funct Integr Genomics"},{"key":"3198_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41568-022-00531-9","volume":"23","author":"AT Ruffin","year":"2023","unstructured":"Ruffin AT, Li H, Vujanovic L, Zandberg DP, Ferris RL, Bruno TC. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. Nat Rev Cancer. 2023;23:173\u201388. https:\/\/doi.org\/10.1038\/s41568-022-00531-9.","journal-title":"Nat Rev Cancer"},{"key":"3198_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4161\/cam.21832","volume":"6","author":"Z Ding","year":"2012","unstructured":"Ding Z, Bae YH, Roy P. Molecular insights on context-specific role of profilin-1 in cell migration. Cell Adh Migr. 2012;6:442\u20139. https:\/\/doi.org\/10.4161\/cam.21832.","journal-title":"Cell Adh Migr"},{"key":"3198_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.febslet.2006.12.013","volume":"581","author":"D Polet","year":"2007","unstructured":"Polet D, Lambrechts A, Vandepoele K, Vandekerckhove J, Ampe C. On the origin and evolution of vertebrate and viral profilins. FEBS Lett. 2007;581:211\u20137. https:\/\/doi.org\/10.1016\/j.febslet.2006.12.013.","journal-title":"FEBS Lett"},{"key":"3198_CR13","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/bies.200900049","volume":"31","author":"EG Yarmola","year":"2009","unstructured":"Yarmola EG, Bubb MR. How depolymerization can promote polymerization: the case of actin and profilin. Bioessays. 2009;31:1150\u201360. https:\/\/doi.org\/10.1002\/bies.200900049.","journal-title":"Bioessays"},{"key":"3198_CR14","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1242\/dev.02590","volume":"133","author":"A Sato","year":"2006","unstructured":"Sato A, Khadka DK, Liu W, Bharti R, Runnels LW, Dawid IB, et al. Profilin is an effector for Daam1 in non-canonical Wnt signaling and is required for vertebrate gastrulation. Development. 2006;133:4219\u201331. https:\/\/doi.org\/10.1242\/dev.02590.","journal-title":"Development"},{"key":"3198_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ydbio.2009.06.008","volume":"332","author":"DK Khadka","year":"2009","unstructured":"Khadka DK, Liu W, Habas R. Non-redundant roles for Profilin2 and Profilin1 during vertebrate gastrulation. Dev Biol. 2009;332:396\u2013406. https:\/\/doi.org\/10.1016\/j.ydbio.2009.06.008.","journal-title":"Dev Biol"},{"key":"3198_CR16","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1084\/jem.191.10.1675","volume":"191","author":"J Janke","year":"2000","unstructured":"Janke J, Schluter K, Jandrig B, Theile M, Kolble K, Arnold W, et al. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J Exp Med. 2000;191:1675\u201386. https:\/\/doi.org\/10.1084\/jem.191.10.1675.","journal-title":"J Exp Med"},{"key":"3198_CR17","doi-asserted-by":"publisher","first-page":"21547","DOI":"10.1073\/pnas.1002309107","volume":"107","author":"YH Bae","year":"2010","unstructured":"Bae YH, Ding Z, Das T, Wells A, Gertler F, Roy P. Profilin1 regulates PI(3,4)P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA-MB-231 cells. Proc Natl Acad Sci USA. 2010;107:21547\u201352. https:\/\/doi.org\/10.1073\/pnas.1002309107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3198_CR18","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/onc.2013.166","volume":"33","author":"Z Ding","year":"2014","unstructured":"Ding Z, Joy M, Bhargava R, Gunsaulus M, Lakshman N, Miron-Mendoza M, et al. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene. 2014;33:2065\u201374. https:\/\/doi.org\/10.1038\/onc.2013.166.","journal-title":"Oncogene"},{"key":"3198_CR19","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3892\/ijo.2018.4475","volume":"53","author":"H Zhang","year":"2018","unstructured":"Zhang H, Yang W, Yan J, Zhou K, Wan B, Shi P, et al. Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer. Int J Oncol. 2018;53:1118\u201328. https:\/\/doi.org\/10.3892\/ijo.2018.4475.","journal-title":"Int J Oncol"},{"key":"3198_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0884-y","volume":"14","author":"XB Cui","year":"2016","unstructured":"Cui XB, Zhang SM, Xu YX, Dang HW, Liu CX, Wang LH, et al. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma. J Transl Med. 2016;14:137. https:\/\/doi.org\/10.1186\/s12967-016-0884-y.","journal-title":"J Transl Med"},{"key":"3198_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3892\/or.2011.1365","volume":"26","author":"CY Ma","year":"2011","unstructured":"Ma CY, Zhang CP, Zhong LP, Pan HY, Chen WT, Wang LZ, et al. Decreased expression of profilin 2 in oral squamous cell carcinoma and its clinicopathological implications. Oncol Rep. 2011;26:813\u201323. https:\/\/doi.org\/10.3892\/or.2011.1365.","journal-title":"Oncol Rep"},{"key":"3198_CR22","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3727\/096504019X15579146061957","volume":"27","author":"K Zhou","year":"2019","unstructured":"Zhou K, Chen J, Wu J, Xu Y, Wu Q, Yue J, et al. Profilin 2 promotes proliferation and metastasis of head and neck cancer cells by regulating PI3K\/AKT\/beta-catenin signaling pathway. Oncol Res. 2019;27:1079\u201388. https:\/\/doi.org\/10.3727\/096504019X15579146061957.","journal-title":"Oncol Res"},{"key":"3198_CR23","doi-asserted-by":"publisher","first-page":"e51136","DOI":"10.1371\/journal.pone.0051136","volume":"7","author":"CJ Groger","year":"2012","unstructured":"Groger CJ, Grubinger M, Waldhor T, Vierlinger K, Mikulits W. Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression. PLoS ONE. 2012;7:e51136. https:\/\/doi.org\/10.1371\/journal.pone.0051136.","journal-title":"PLoS ONE"},{"key":"3198_CR24","doi-asserted-by":"publisher","first-page":"145614","DOI":"10.1016\/j.gene.2021.145614","volume":"787","author":"SI Gul","year":"2021","unstructured":"Gul SI, Ayoub A, Ali SA, Hanook S, Baig DN. Profilin 3 genetic architecture in glioma formalin fixed paraffin embedded (FFPE) archive. Gene. 2021;787:145614. https:\/\/doi.org\/10.1016\/j.gene.2021.145614.","journal-title":"Gene"},{"key":"3198_CR25","doi-asserted-by":"publisher","unstructured":"Li H, Hou L, Zhang Y, Jiang F, Zhu Y, Li QX, et al. PFN2a suppresses C2C12 myogenic development by inhibiting proliferation and promoting apoptosis via the p53 pathway. Cells. 2019;8. https:\/\/doi.org\/10.3390\/cells8090959.","DOI":"10.3390\/cells8090959"},{"key":"3198_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12282-020-01169-x","volume":"28","author":"Y Ling","year":"2021","unstructured":"Ling Y, Cao Q, Liu Y, Zhao J, Zhao Y, Li K, et al. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells. Breast Cancer. 2021;28:368\u201378. https:\/\/doi.org\/10.1007\/s12282-020-01169-x.","journal-title":"Breast Cancer"},{"key":"3198_CR27","first-page":"233","volume":"62","author":"Y Hippo","year":"2002","unstructured":"Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong JM, Fukayama M, et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002;62:233\u201340.","journal-title":"Cancer Res"},{"key":"3198_CR28","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3892\/or.2017.5566","volume":"37","author":"J Yan","year":"2017","unstructured":"Yan J, Ma C, Gao Y. MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines. Oncol Rep. 2017;37:3146\u201354. https:\/\/doi.org\/10.3892\/or.2017.5566.","journal-title":"Oncol Rep"},{"key":"3198_CR29","doi-asserted-by":"publisher","first-page":"25981","DOI":"10.18632\/aging.202213","volume":"12","author":"Q Cao","year":"2020","unstructured":"Cao Q, Liu Y, Wu Y, Hu C, Sun L, Wang J, et al. Profilin 2 promotes growth, metastasis, and angiogenesis of small cell lung cancer through cancer-derived exosomes. Aging. 2020;12:25981\u201399. https:\/\/doi.org\/10.18632\/aging.202213.","journal-title":"Aging"},{"key":"3198_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9230","volume":"6","author":"YN Tang","year":"2015","unstructured":"Tang YN, Ding WQ, Guo XJ, Yuan XW, Wang DM, Song JG. Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis. Nat Commun. 2015;6:8230. https:\/\/doi.org\/10.1038\/ncomms9230.","journal-title":"Nat Commun"},{"key":"3198_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3892\/ol.2018.9636","volume":"17","author":"G Assani","year":"2019","unstructured":"Assani G, Zhou Y. Effect of modulation of epithelial-mesenchymal transition regulators Snail1 and Snail2 on cancer cell radiosensitivity by targeting of the cell cycle, cell apoptosis and cell migration\/invasion. Oncol Lett. 2019;17:23\u201330. https:\/\/doi.org\/10.3892\/ol.2018.9636.","journal-title":"Oncol Lett"},{"key":"3198_CR32","first-page":"5165","volume":"60","author":"LM Butler","year":"2000","unstructured":"Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, et al. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res. 2000;60:5165\u201370.","journal-title":"Cancer Res"},{"key":"3198_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.exphem.2004.09.008","volume":"33","author":"S Sakajiri","year":"2005","unstructured":"Sakajiri S, Kumagai T, Kawamata N, Saitoh T, Said JW, Koeffler HP. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. Exp Hematol. 2005;33:53\u201361. https:\/\/doi.org\/10.1016\/j.exphem.2004.09.008.","journal-title":"Exp Hematol"},{"key":"3198_CR34","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1158\/1078-0432.CCR-06-0367","volume":"12","author":"QT Luong","year":"2006","unstructured":"Luong QT, O\u2019Kelly J, Braunstein GD, Hershman JM, Koeffler HP. Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo. Clin Cancer Res. 2006;12:5570\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0367.","journal-title":"Clin Cancer Res"},{"key":"3198_CR35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.oraloncology.2008.11.009","volume":"45","author":"T Nagumo","year":"2009","unstructured":"Nagumo T, Takaoka S, Yoshiba S, Ohashi M, Shirota T, Hatori M, et al. Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo. Oral Oncol. 2009;45:766\u201370. https:\/\/doi.org\/10.1016\/j.oraloncology.2008.11.009.","journal-title":"Oral Oncol"},{"key":"3198_CR36","doi-asserted-by":"publisher","unstructured":"Regmi P, Lai KC, Liu CJ, Lee TC. SAHA overcomes 5-FU resistance in IFIT2-depleted oral squamous cell carcinoma cells. Cancers. 2020;12. https:\/\/doi.org\/10.3390\/cancers12123527.","DOI":"10.3390\/cancers12123527"},{"key":"3198_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1515\/hsz-2015-0215","volume":"397","author":"S Wu","year":"2016","unstructured":"Wu S, Luo Z, Yu PJ, Xie H, He YW. Suberoylanilide hydroxamic acid (SAHA) promotes the epithelial mesenchymal transition of triple negative breast cancer cells via HDAC8\/FOXA1 signals. Biol Chem. 2016;397:75\u201383. https:\/\/doi.org\/10.1515\/hsz-2015-0215.","journal-title":"Biol Chem"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03198-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03198-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03198-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:54:08Z","timestamp":1768917248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03198-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,31]]}},"alternative-id":["3198"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03198-9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of MacKay Memorial Hospital (approval number: 20MMHIS437e), and written informed consent was obtained from all participants. All procedures were performed in accordance with the relevant guidelines and regulations. Animal experiments were approved by the Institutional Animal Care and Use Committee of MacKay Memorial Hospital (approval number: MMH-A-S-107-70) and conducted in compliance with institutional and international standards for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have approved the manuscript and agree with its submission to Cancer Science.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}